Clinical Trials Browser

Phase 4 × Ovarian Neoplasms × 90 days × Clear all

NCT06412120 2026-03-16

Study Evaluating Safety, Tolerability, and Metabolism of Niraparib

Phase 4 Recruiting

Ovarian Neoplasms

NCT07469202 2026-03-13

CYTALUX Dose Extension Study

Phase 4 Not yet recruiting

GynecologicThoracic

Lung Neoplasms, Ovarian Neoplasms